Cargando…

Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST)

BACKGROUND: Febrile Urinary Tract Infection (FUTI) is frequently treated initially with intravenous antibiotics, followed by oral antibiotics guided by clinical response and bacterial susceptibility patterns. Due to increasing infection rates with multiresistant Enterobacteriaceae, antibiotic option...

Descripción completa

Detalles Bibliográficos
Autores principales:	ten Doesschate, Thijs, van Mens, Suzan P., van Nieuwkoop, Cees, Geerlings, Suzanne E., Hoepelman, Andy I. M., Bonten, Marc J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280543/ https://www.ncbi.nlm.nih.gov/pubmed/30518334 http://dx.doi.org/10.1186/s12879-018-3562-2

Ejemplares similares

Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial( )
por: ten Doesschate, Thijs, et al.
Publicado: (2021)

Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the Prostate
por: Sobels, Annemieke, et al.
Publicado: (2022)

In vivo acquisition of fosfomycin resistance in Escherichia coli by fosA transmission from commensal flora
por: ten Doesschate, Thijs, et al.
Publicado: (2019)

FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients—efficacy and microbiologic safety
por: Moreno, Ainhoa Fernández, et al.
Publicado: (2023)

In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates
por: Liu, Yanyan, et al.
Publicado: (2019)

Fosfomycin: Pharmacological, Clinical and Future Perspectives
por: Dijkmans, Anneke Corinne, et al.
Publicado: (2017)

Effectiveness of extended- versus normal-release nitrofurantoin for cystitis: an instrumental variable analysis
por: ten Doesschate, Thijs, et al.
Publicado: (2019)

Treatment Duration of Febrile Urinary Tract Infections
por: van der Starre, Willize E., et al.
Publicado: (2011)

Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms
por: Wang, Lei, et al.
Publicado: (2019)

Protein Homeostasis Database: protein quality control in E.coli
por: Ramakrishnan, Reshmi, et al.
Publicado: (2019)

Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women
por: van Nieuwkoop, Cees, et al.
Publicado: (2017)

Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection
por: Kuiper, Sander G, et al.
Publicado: (2020)

Comparison of a combined regimen of fosfomycin and ciprofloxacin with ciprofloxacin alone as antimicrobial prophylaxis for transrectal prostate biopsy in the era of high fluoroquinolone-resistant rectal flora
por: Lim, Do Gyeong, et al.
Publicado: (2021)

Design of an improved multiplex PCR method for diagnosis of enterohaemoraghic E.coli and enteropathogic E.coli pathotypes
por: Soleimani, Mohammad, et al.
Publicado: (2012)

Efficacy of Single Dose of Fosfomycin Versus a Five-Day Course of Ciprofloxacin in Patients With Uncomplicated Urinary Tract Infection
por: Hassan, Muhammad Mujeeb, et al.
Publicado: (2022)

Comparison of amikacin with fosfomycin as an add-on to ciprofloxacin for antibiotic prophylaxis in transrectal prostate biopsy: A single-center retrospective study
por: Yu, Seong Hyeon, et al.
Publicado: (2022)

Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens
por: Ortiz Zacarías, Natalia V., et al.
Publicado: (2018)

Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus
por: Ruan, Zijing, et al.
Publicado: (2020)

Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial()
por: ten Doesschate, Thijs, et al.
Publicado: (2022)

Urinary Proteins, Vitamin D and Genetic Polymorphisms as Risk Factors for Febrile Urinary Tract Infection and Relation with Bacteremia: A Case Control Study
por: van der Starre, Willize E., et al.
Publicado: (2015)

Fosfomycin and breastfeeding
Publicado: (2020)

Fosfomycin trometamol vs ciprofloxacin for antibiotic prophylaxis before transrectal ultrasonography-guided prostate biopsy: A meta-analysis of clinical studies
por: Freitas, Daniel Melecchi de Oliveira, et al.
Publicado: (2019)

Diabetes and the Course of Febrile Urinary Tract Infection
por: van der Starre, Willize E., et al.
Publicado: (2013)

An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial
por: Randremanana, Rindra Vatosoa, et al.
Publicado: (2020)

Obesity in school-aged children and its correlation with Gut E.coli and Bifidobacteria: a case–control study
por: Gao, Xiaolin, et al.
Publicado: (2015)

Studying of Membrane Localization of Recombinant Potassium Channels in E.coli
por: Nekrasova, O., et al.
Publicado: (2009)

Swimming and rafting of E.coli microcolonies at air–liquid interfaces
por: Sinibaldi, Giorgia, et al.
Publicado: (2017)

Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials
por: ten Doesschate, Thijs, et al.
Publicado: (2020)

Different effects of cortisol on pro-inflammatory gene expressions in LPS-, heat-killed E.coli-, or live E.coli-stimulated bovine endometrial epithelial cells
por: Cui, Luying, et al.
Publicado: (2020)

Correction to: Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials
por: ten Doesschate, Thijs, et al.
Publicado: (2020)

611. Fosfomycin Resistance of Multidrug-Resistant Escherichia coli and Mechanisms of Fosfomycin Resistance
por: Seok, Hyeri, et al.
Publicado: (2019)

Antisense RNA based down-regulation of RNaseE in E.coli
por: Kemmer, Christian, et al.
Publicado: (2006)

EcoliWiki: a wiki-based community resource for Escherichia coli
por: McIntosh, Brenley K., et al.
Publicado: (2012)

Proteomic Differences between Tellurite-Sensitive and Tellurite–Resistant E.coli
por: Aradská, Jana, et al.
Publicado: (2013)

EcoliNet: a database of cofunctional gene network for Escherichia coli
por: Kim, Hanhae, et al.
Publicado: (2015)

Identifying Risk Factors and Improving Preventive Strategies for Febrile Neutropenia in Children with Leukemia Receiving Ciprofloxacin Prophylaxis
por: Kaya, Zühre, et al.
Publicado: (2023)

Fosfomycin in antimicrobial stewardship programs
por: Rubio, Elena Múñez, et al.
Publicado: (2019)

Deciphering pharmacokinetics and pharmacodynamics of fosfomycin
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2019)

New microbiological aspects of fosfomycin
por: Díez-Aguilar, María, et al.
Publicado: (2019)

The role of fosfomycin in osteoarticular infection
por: Morata, Laura, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gld010vqqkp64nv48nl4ohf8k5